2 Top Stocks Beaten Down Near 52-Week Lows That Look Like Bargains Now

Group 1: Pfizer - Pfizer's shares have declined approximately 57% from their peak in late 2021, primarily due to faster-than-expected declines in COVID-19 product sales and upcoming patent cliffs for top-selling products [3][4] - Despite the stock price drop, Pfizer has maintained its dividend payout, raising it for the 16th consecutive year, resulting in a substantial 6.6% dividend yield at recent prices [3][7] - In 2024, sales of the blood thinner Eliquis grew by 9% to $7.4 billion, accounting for 11.6$15.51 per share [8] - The company has the ability to raise premiums to maintain profitability, as options in the insurance industry have become limited due to consolidation [9] - UnitedHealth Group employs 90,000 physicians through its Optum Health division, which represents roughly 10% of the total physician workforce in the U.S., allowing for better control over medical expenses [10][11] - Despite the stock price decline, UnitedHealth Group has increased its dividend payout by 94% over the past five years, although the current yield is only 0.4% [12]